ArticleBioinformatics (Oxford, England)2026
Predicting condition-aware drug-induced transcriptional responses via a latent diffusion model.
Article in Bioinformatics (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
motivationAccurate prediction of condition-aware drug-induced transcriptional responses is essential for drug discovery and precision medicine. Current computational models, including encoder-decoder architectures and generative adversarial network-based approaches, exhibit reasonable performance but frequently neglect biological characteristics and fail to generalize to unseen conditions. Thus, this study presents a latent diffusion model that combines a variational autoencoder (VAE) with a diffusion process.
resultsThe VAE compresses gene expression (GE) profiles into a low-dimensional latent space, where the diffusion process learns the joint probability distribution over latent GE representations and noisy intermediates, thereby enabling more effective capture of gene-gene correlations. The model incorporates multiple perturbation conditions, including cell line, compound, dose, and time, to enhance prediction performance on unseen conditions. The reverse diffusion process predicts both the mean and variance of the posterior distribution, improving the fidelity of the generated GE profiles. The proposed model achieved the highest reconstruction performance in the unseen compound split with a Pearson correlation coefficient of 0.870 ± 0.001 and an R2 score of 0.739 ± 0.001, outperforming previous approaches. The model demonstrated superior preservation of gene-gene correlations, as confirmed by heatmap analysis. To evaluate biological relevance, we predicted half-maximal inhibitory concentration using generated GE, outperforming baseline methods. Latent space analysis revealed that the model preserved cell line identity and continuous dose-time variation. Gene set enrichment analysis confirmed that predicted GE reproduced known pathway-level responses to perturbation. These results demonstrate diffusion-based generative models as effective tools for modeling transcriptional responses in drug discovery and precision medicine. AVAILABILITY AND IMPLEMENTATION: Source code and dataset are available at https://doi.org/10.5281/zenodo.18871024.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.